PPARGC1A and metabolic dysfunction-associated steatotic liver disease: Figure 1C also shows that PGC1α expression is very high in postmenopausal women; it is also closely associated with BC risk and reduced overall survival. More recently, NAFLD has been identified as a possible contributor to BC progression in women [60].